 Hemiparesis ischemic changes white matter intrathecal therapy children acute lymphocytic leukemia children acute lymphocytic leukemia ALL delayed-onset transient hemiparesis facial palsy intrathecal IT administration methotrexate MTX part triple intrathecal chemotherapy central nervous system CNS prophylaxis hemiparesis days IT therapy children transient profound expressive dysarthria episodes maintenance treatment multiple IT administrations previous CNS toxicity children intermediate-dose MTX weeks events patients cranial irradiation evidence CNS leukemia episodes Ischemic changes computerized tomographic scan magnetic resonance studies cases Such changes unusual manifestations neurotoxicity children intrathecal therapy